How are the Premier's Awards helping cancer researchers?
2 May 2019
The Premier’s Awards not only recognise the state’s top cancer researchers but also propels their work to greater heights.
Hear from the 2017 winners and find out how it is influencing their work:
Professor Helen Rizos
Melanoma Translational Research Team – Wildfire Highly Cited Publication Award
The award is allowing Professor Rizos’ team to extend their research into regulating melanoma gene expression and its role in the response of melanoma to immunotherapy.
Professor Richard Scolyer and Professor Georgina Long
Melanoma Institute Australia – Excellence in Translational Cancer Research Award
The award is supporting a plethora of Melanoma Institute Australia research projects that made headlines around the world. These include discovering the specific mechanisms behind immune-mediated equilibrium
Professor Scolyer and Professor Long won major awards at the 2018
Professor Richard Kefford
Macquarie University – Outstanding Cancer Researcher of the Year Award
Professor Kefford’s is commissioning a tailor-made, melanoma-specific gene mutation panel for DNA sequencing machinery in their laboratory. The award is enabling his team to extend their research into regulating melanoma gene expression and its role in the response of melanoma to immunotherapy.
International collaboration the key to increasing survival
"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.
High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
Monthly dose of immunotherapy allows flexibility for patients undergoing treatment
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
Australia's best minds in melanoma research converge on Melbourne
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
Nobel Prize for novel cancer therapies
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
World Health Organisation launches 4th edition of Classification of Skin Tumours
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Support PBS listing for pembrolizumab
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
World Congress on Cancers of the Skin 2018
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia welcomes new CEO Matthew Browne
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
Melanoma in Practice: Nurse Conference
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
Reducing the risk of melanoma in young adults
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia launches free e-learning education portal
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
David Day and a lifetime of missed moments
When David lost his life last year, he was 33, with three daughters under six.
Australian melanoma experts share latest breakthroughs with world's best oncologists
ASCO 2018 brings together the world's best in oncology from around the world.
ASCO 2018 – the important role of clinical trials
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
MIA Scoops Awards at the International Academy of Pathology
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Updated Clinical Guidelines for Melanoma
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
Melanoma and Marital Status: A Study
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
A weekend in Paris talking all things pathology...
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.